BackEagle Pharmaceuticals Overview

Eagle Pharmaceuticals Operating Income

Operating Income for EGRX.

Quarterly Operating Income

$10.30M
↑ 367.73% YoY

As of Jun 30, 2023

Annual Operating Income (TTM)

$35.42M
↓ 38.67% YoY

Trailing 12 months ending Jun 30, 2023

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin